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Abstract
Aim The aim of this study is to prospectively evaluate 40
patients with a high rectovaginal fistula treated by a
laparoscopic fistula division and closure, followed by an
omentoplasty.
Patients and methods Forty patients with a rectovaginal
fistula, between the middle third of the rectum and the
posterior vaginal fornix, resulting from different causes
(IBD, iatrogenic and birth trauma) were treated by a
laparoscopic excision of the fistula and insertion of an
omentoplasty in the rectovaginal septum. The patients
completed the gastrointestinal quality of life index ques-
tionnaire (GIQLI) and the Cleveland Clinic incontinence
score (CCIS). All tests were performed at regular intervals
after treatment.
Results In 38 (95%) patients with a median age of 53 years
(range 33–72), the surgical procedure was feasible. In two
patients, the fistula was closed without an omentoplasty,
and a diverting stoma was performed. The median follow-
up was 28 months (range 10–35). Two patients (5%)
developed a recurrent fistula. In one patient, the interposed
omentum became necrotic and was successfully treated
laparoscopically. In another patient, an abscess developed,
which needed drainage procedures. The mean CCIS was 9
(range 7–10) before treatment and 10 (range 7–13) after
treatment (p=0.5 Wilcoxon). The median GIQLI score was
85 (range 34–129) before treatment and 120 (range75–142)
after treatment (p=0.0001, Wilcoxon).
Conclusions Laparoscopic fistula excision combined with
omentoplasty is a good treatment modality with a high
healing rate for high rectovaginal fistulas and an acceptable
complication rate.
Keywords Omentoplasty.Omentum.Laparoscopic fistula
excision.Rectovaginal fistulas.Rectovaginal septum
Introduction
Rectovaginal fistulas significantly reduce the quality of life
of affected women and represent a challenge for surgeons.
The vaginal passage of gas and stool can cause physical
symptoms due to inflammation and irritation. Patients may
also suffer from significant psychosocial and sexual
dysfunction [1].
The treatment of rectovaginal fistulas depends on size,
location, cause, continence, and overall health status of
the patient. The transanal endorectal advancement flap is
the most popular technique to repair simple low
rectovaginal fistulas by colorectal surgeons, while the
gynecologists prefer the transvaginal approach. The
transabdominal approach is the standard surgical ap-
proach for high fistulas with large defects [2, 3]. This
technique includes fistula division and closure with or
without bowel resection and interposition of local flaps,
such as muscle and musculocutaneous flaps. In most
techniques, diversion colostomy is preferred to safeguard
the procedure [2, 3].
In the present study, no diversion colostomy was
deemed necessary if the omentum is interposed between
the properly sutured defects remaining after fistula
division and excision. The laparoscopic repair of recto-
vaginal fistulas has all the advantages of minimal access
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tions, less postoperative pain, and early discharge of the
patient. The technique can replace the transanal or
transvaginal approach if the rectovaginal septum is
opened as distal as the pelvic floor. In this study, we
investigated the results of a laparoscopic transabdominal
approach in patients with high rectovaginal fistulas by
excision and closure of the fistulous tract followed by an
omentoplasty.
Patients and methods
Between 2006 and 2009, patient characteristics like age,
fistula cause, and previous surgical attempts were
recorded of all consecutive patients with a rectovaginal
fistula. The patients underwent physical examination,
transvaginal ultrasound, and proctosigmoidoscopy as a
standard procedure. Because high rectovaginal fistulas
c a nb ee a s i l ym i s s e db yb o t hp h y s i c a le x a m i n a t i o na n d
endoscopy, methylene blue enemas with a vaginal
tampon in place were used for the confirmation of
diagnosis. A fistula between the middle third of the
rectum and the posterior vaginal fornix was defined as a
high fistula.
Only patients with a confirmed high fistula were recruited
for this study. The study protocol was approved by the ethical
committee. Written informed consent was obtained before
entering the study. Before treatment and at 12 months after
treatment, the patients filled out the gastrointestinal quality of
lifeindexquestionnaireandtheClevelandClinicincontinence
score. Patients younger than 18, patients with malignancy,
patients that had received radiation therapy, or patients who
were HIV-infected were excluded.
Procedure
After the induction of general anaesthesia, 2,200 mg
amoxicillin/clavulanic acid was given intravenously.
Cleansing of the vaginal lumen with an antiseptic solution
(povidone–iodine) was done. A Foley catheter was inserted
into the urinary bladder. The procedure was performed with
the patient in a semi-lithotomy position, with the legs in a
downwards position. After reaching the pneumoperito-
neum, the patient was placed in a Trendelenburg position.
Four trocars were placed. The ileum loops were gently
moved out of the pelvic cavity, and the sigmoid loop is
withdrawn in a left cranial position.
Possible adhesions between the rectum and the bladder
peritoneum were dissected. A peritoneal incision was made
over the sacral promontory and extended caudally along the
rectum over the deepest part of the pouch of Douglas.
Denonvilliers' fascia was incised. The (fibrotic) fistula was
identified and was divided. After the fistulous tract was
opened, the rectal and vaginal sides of the fistula were
identified. The fistula tract was resected, and the rectova-
ginal septum broadly opened down to the pelvic floor.
The opening of the fistula on the rectal side was closed
in two layers with 2–0 Vicryl by intracorporeal suturing.
The vaginal side was closed with 2–0 Vicryl in a single
continuous layer.
Afterplacingthepatientintheanti-Trendelenburgposition,
the omentum was dissected free from the transverse colon.
The right or left gastroepiploic artery is dissected, and the
omentum was mobilized by cutting the gastroepiploic arcade
atoneside.Subsequently,theomentumisbroughtdowntothe
pelvis either by tunneling it through the mesocolon or
positioning it in the left or right paracolic gutters. Finally,
the omentum was placed between the repaired rectum and the
repairedvaginaandsutured tothe pelvicfloor.The abdominal
cavity was rinsed with 2 l of NaCl. A drain was placed in the
pelvis through the right flank and removed within 2 days
when discharge was negligible.
Intention to treat
In this study, the results of all patients that were included to
undergo this procedure were analyzed. If an omentoplasty
was not feasible, the fistula was closed and a diverting
stoma was performed.
Examination
Patients were followed at regular intervals of 2 months at
the outpatient clinic and were re-examined for the
purpose of this study. The fistula was considered to be
healed if there were no passage of gas and stool and no
physical symptoms due to inflammation and irritation.
All of the patients received after 6 months a methylene
blue rectal enema and a vaginal tampon to confirm that
the fistula was closed. Continence disorders were
examined by the Cleveland Clinic incontinence score
before treatment and at 12 months after treatment. Before
treatment and 12 months after treatment, the patients
filledinthegastrointestinalqualityoflifeindexquestionnaire.
Hospital stay, operation time, and complications were
recorded.
Statistical analysis
Comparisons were made between the outcome obtained
before treatment and at 12 months after treatment. Statis-
tical analysis included two-tailed t tests and two-way
analysis for the observed changes in the faecal incontinence
and quality of life scales. A probability of 0.05 was
considered significant.
1464 Int J Colorectal Dis (2011) 26:1463–1467Results
Forty consecutive patients with a median age of 53 years
(range 33–72) with a rectovaginal fistula were included.
The patients' characteristics and outcomes are described in
Table 1.
In 38 (95%) patients, the laparoscopic omentoplasty was
feasible. The median hospital stay was 4 days (range 2–7).
The median operation time amounted to 133 min (range
118–173). The median follow-up was 28 months (range
10–35).
There was no difference in incontinence disorders before
and after treatment. The mean CCIS was 9 (range 7–10)
before treatment and 10 (range 7–13) after treatment (p=0.5,
Wilcoxon).
The median GIQLI score was 85 (range 34–129) before
treatment and 120 (range75–142) after treatment (p=0.0001,
Wilcoxon). The domain scores are listed in Table 2.
Complications
In two patients, the fistula was closed without an
omentoplasty because of an unsuitable omentum. In these
patients, a diverting stoma was performed. Two patients
(5%) developed a recurrent fistula during follow-up. The
patient with a recurrent fistula in the postsurgery group did
not want a new surgical intervention because of minor
complaints of the fistula. The patient with the recurrent
fistula and Crohn's disease underwent a diverting stoma.
In one patient, a necrotic omentum developed. This was
successfully treated by a laparoscopic necrotectomy. In
another patient, an abscess developed, which needed
drainage procedures. Minor complications included gastric
retention and urinary infection (Table 3).
Discussion
Rectovaginal fistulas can develop from several condi-
tions, including obstetric trauma, inflammatory bowel
disease (IBD), carcinoma, radiation, diverticulitis, and
infectious processes, and as a result of postsurgical
procedures. The most common cause of rectovaginal
fistulas is obstetric trauma because of prolonged labor.
Predisposing factors include forceps delivery, midline
episiotomy, and third- or fourth-degree perineal lacera-
tions [4]. The second most common cause of rectovaginal
fistulas is inflammatory bowel disease, specifically
Crohn's disease. Rectovaginal fistulas have been reported
to occur in 9–10% of patients. Radcliffe et al. reported an
incidence of 9.8% of rectovaginal fistulas in women with
Crohn's disease [5]. Malignant processes, including cancer
of the rectum, cervix, uterus, or vagina, can also contribute
to the development of a rectovaginal fistula. In addition,
the fistulas can develop as complications of radiation
therapy and postsurgical complications including low
anterior resection with stapled anastomosis, hysterectomy,
rectocele repair, and restorative proctocolectomy with ileal
pouch anastomosis.
In the present study, a relatively high number of
patients [18 (45%)] were treated for a rectovaginal fistula
because of postsurgical complications after hysterectomy
Table 2 GIQLI score and CCIS
Total gastrointestinal quality of life index and
domain scores and CCIS
Preoperative After treatment P value
Total GIQLI score 85 (34–129) 120 (75–142) <0.00001
Symptoms 44 (21–670) 62 (41–74) <0.00001
Physical function 13 (3–26) 23 (7–28) <0.00001
Social function 10.5 (3–15) 14 (8–17) <0.0001
Emotional function 11 (1–19) 17 (5–21) <0.00001
Subjective treatment
assessment
3( 0 –4) 4 (1–4) <0.00015
CCIS 9 (range 7–10) 10 (range 7–13) 0.5
Stomach distension 5
Trocar wound infection 1
Urinary tract infection 3
Table 3 Minor complications
Table 1 Patients' characteristics and outcome
IBD, N=3 (8%) Birth trauma, N=19 (47%) Postsurgery, N=18 (45%) N=40
>1 previous surgical attempt in history 3 10 8
Failure of omentoplasty 0 0 2 2 (5%)
Recurrent fistula 1 0 1 2 (5%)
Hospital stay (days) 4 (3–5) 4 (2–6) 4 (3–7) 4 (2–7)
Operation time (min) 127 (120–135) 127 (118–140) 145 (128–173) 128 (118–173)
Int J Colorectal Dis (2011) 26:1463–1467 1465and/or rectocele repair. In ten of these patients, not only
the fistula was excised but also the mesh had to be
removed, which required a prolonged operation time in
this special group. Rectovaginal fistulas resulting from
radiation therapy are treated in our clinic by bowel
resection and colostomy.
The successful management of rectovaginal fistulas
depends on a variety of factors including etiology, size,
and location of the fistula. Especially, the management of
rectovaginal fistulas in patients with Crohn's disease is still
extremely challenging and the recurrence rate varies
between 50% and 100% [6, 7]. The recurrence rate of
traumatic and obstetric rectovaginal fistulas varies between
11% and 25% [6, 8].
Various therapies have been proposed, such as advance-
ment flap plasties or bioprosthetic plugs, applied trans-
vaginally or transanally especially for the treatment of low
rectovaginal fistulas [9–14]. In patients with high rectova-
ginal fistulas, especially in Crohn's disease, the trans-
abdominal approach is the most frequently published.
Bowel resections, Gracilis transposition, proctectomy, and
diversion colostomy are commonly performed when cure is
not to be expected [2, 3, 14, 15].
Rectovaginal fistulas in IBD are frequently treated by
infliximab without surgery. The closure rate is about 30–50%
[1, 16, 17]. Another study suggested the effectiveness of
staged definitive surgery combined with infliximab in the
treatment of patients with Crohn's disease [18]. In the present
study, only three (8%) patients with IBD were included: two
patients with Crohn's disease and one with ulcerative colitis.
One patient had been treated previously with infliximab, but
all three patients with IBD were on maintenance therapy
with azathioprine and one with corticosteroids. None of them
had active rectal disease at the time of treatment by
laparoscopic omentoplasty.
Several studies have reported cases of rectovaginal fistula
repair by laparoscopy [19–21]. Pelosi et al. performed
laparoscopic upper rectovaginal mobilization to facilitate
the transvaginal repair of recurrent rectovaginal fistula [22].
Schwenk et al. reported a case of a rectovaginal fistula for
which they had performed a laparoscopic resection of the
sigmoid colon which included the fistulous tract, after which
an intracorporeal colorectal anastomosis was performed
together with an omentoplasty [23].
The effectiveness of intra-abdominal use of an
omentoplasty is described in several studies in patients
especially with hydatic cysts to overcome surgical site
infections and fistulas [24–27], but no series of patients
with rectovaginal fistulas, treated by complete laparoscop-
ic repair or treated by omentoplasty, have been published
in the literature.
Our study shows that laparoscopic fistula excision and
omentoplasty for high rectovaginal fistulas can be performed
safelyandwithashorthospitalstay,alowrecurrencerate,and
without requiring a diverting colostomy.
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